New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
05:52 EDTAMPEAmpio initiates clinical trial of Optina in DME, first patient dosed
Ampio Pharmaceuticals announced oral dosing of the first patient in a 505b2 clinical trial of the investigational drug Optina in diabetic macular edema, or DME. The trial will evaluate Optina in adults with recent onset diabetic macular edema. Last year, the FDA granted Optina 505b2 status and drugs designated under this pathway can be approved on a single trial.
News For AMPE From The Last 14 Days
Check below for free stories on AMPE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
09:07 EDTAMPEOn The Fly: Pre-market Movers
Subscribe for More Information
07:56 EDTAMPEAmpio delays data analysis of STEP Study due to temperature deviations
Subscribe for More Information
August 20, 2014
11:42 EDTAMPEOptions with decreasing implied volatility
Subscribe for More Information
August 19, 2014
10:42 EDTAMPEOptions with decreasing implied volatility
Subscribe for More Information
August 18, 2014
09:03 EDTAMPEOn The Fly: Pre-market Movers
Subscribe for More Information
08:03 EDTAMPEAmpio announces 6-week results of Ampion study
Subscribe for More Information
August 8, 2014
07:04 EDTAMPEAmpio volatility elevated into data release
Subscribe for More Information
August 7, 2014
13:04 EDTAMPEAmpio volatility elevated
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use